Peer-reviewedCC BYFrontiers in oncology
Integrating overall survival and health-related quality of life to prioritize first-line systemic therapies for unresectable advanced gastric cancer: a network meta-analysis
- 1Department of General surgery, Suzhou Ninth Hospital Affiliated to Soochow University , , ,
- 2Department of Interventional Oncology, Renji Hospital, Shanghai Jiao Tong University School of Medicine , ,
- 3Department of Breast Surgery, Renji Hospital, Shanghai Jiao Tong University School of Medicine , ,
Related
- Integrating Magnetic Resonance Imaging-Based Deep Learning and Radiomics to Predict Treatment Response in Hepatocellular Carcinoma Receiving Combined Systemic and Locoregional Therapies: A Multicenter Study.
- Survival outcomes of spleen-strengthening and dampness-eliminating traditional Chinese medicine granules combined with lenvatinib for unresectable hepatocellular carcinoma: a large-sample retrospective study based on electronic medical records
- Survival outcomes of radiotherapy in elderly patients with unresectable stage III hepatocellular carcinoma: a population-based retrospective cohort study
- Complete response in unresectable HER2+ cholangiocarcinoma with histotripsy and systemic therapy followed by liver transplantation: a case report.
- Systemic treatment strategies for BRAF wild-type metastatic unresectable melanoma: a network meta-analysis
BibTeX
@article{wu2026integrating,
title = {{Integrating overall survival and health-related quality of life to prioritize first-line systemic therapies for unresectable advanced gastric cancer: a network meta-analysis}},
author = {Ji Wu and Zhigang Zheng and Xiping Shen and Huijuan Dai and Yefeng Wu},
journal = {Frontiers in oncology},
year = {2026},
month = oct,
url = {https://europepmc.org/article/PMC/PMC13654780},
note = {CC BY},
}
RIS
TY - JOUR
TI - Integrating overall survival and health-related quality of life to prioritize first-line systemic therapies for unresectable advanced gastric cancer: a network meta-analysis
AU - Ji Wu
AU - Zhigang Zheng
AU - Xiping Shen
AU - Huijuan Dai
AU - Yefeng Wu
PY - 2026
DA - 2026/10/16
JO - Frontiers in oncology
UR - https://europepmc.org/article/PMC/PMC13654780
SN - 2234-943X
ER -